NCT07541534 2026-04-21
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Clinical Trials
7 trialsNCT05718895 2026-04-15
CLINCH
Antengene Corporation
Phase 1 Recruiting
NCT07141706 2026-04-09
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1 Recruiting
NCT07480681 2026-03-18
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
NCT07473726 2026-03-16
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
NCT07274813 2026-03-03
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech
Phase EARLY_PHASE1 Recruiting
NCT07415863 2026-02-17
Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2 Recruiting